The impact of COVID-19 on patients with hematological malignancies: the mixed-method analysis of an Israeli national survey
Sign Up to like & getrecommendations! Published in 2021 at "Supportive Care in Cancer"
DOI: 10.1007/s00520-021-06324-4
Abstract: The COVID-19 pandemic required reevaluation of the therapeutic approach and added emotional stress for patients with hematological malignancies at high risk of contracting the virus. We aimed to evaluate how it affected such patients during… read more here.
Keywords: patients hematological; management hematological; national survey; hematological malignancies ... See more keywords
Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies.
Sign Up to like & getrecommendations! Published in 2021 at "European journal of medicinal chemistry"
DOI: 10.1016/j.ejmech.2021.113623
Abstract: Matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) are collectively known as gelatinases whereas MMP-2 is gelatinase-A and MMP-9 is termed as gelatinase-B. Gelatinases and other matrix metalloproteinases (MMPs) have long been associated with solid tumor… read more here.
Keywords: gelatinase; management hematological; matrix metalloproteinase; clinical trials ... See more keywords
Last Trends in Point-of-Care (POC) Diagnostics for the Management of Hematological Indices in Home Care Patients
Sign Up to like & getrecommendations! Published in 2023 at "Biosensors"
DOI: 10.3390/bios13030345
Abstract: Today, complete blood count (CBC) analyses are highly automated and allow for high throughput and accurate and reliable results. However, new analytical tools are in great demand to provide simple, rapid and cost-effective management of… read more here.
Keywords: indices home; hematological indices; care; home care ... See more keywords